Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medical Marijuana Inc MJNA

Healthcare
Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in four divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news... see more

Recent & Breaking News (OTCPK:MJNA)

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker

PR Newswire May 21, 2020

Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®

PR Newswire May 19, 2020

Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program

PR Newswire May 11, 2020

Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer

PR Newswire May 7, 2020

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

PR Newswire May 5, 2020

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Largest Digital Event in Company History

PR Newswire April 30, 2020

Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA

PR Newswire April 29, 2020

Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International

PR Newswire April 22, 2020

Blake Schroeder, CEO of Medical Marijuana, Inc. Subsidiary Kannaway®, Honored as Top CEO of the Year by the International Association of Top Professionals

PR Newswire April 16, 2020

Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President

PR Newswire April 14, 2020

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine(TM)

PR Newswire April 9, 2020

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

PR Newswire April 8, 2020

Medical Marijuana, Inc. CEO Featured in U.S. News and World Report Providing Insight on Penny Stocks

PR Newswire April 2, 2020

HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors

PR Newswire March 31, 2020

Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry

PR Newswire March 26, 2020

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

PR Newswire March 24, 2020

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders

PR Newswire March 19, 2020

Medical Marijuana, Inc. Subsidiary Kannaway® Becomes First Company to Legally Import CBD Products Into Russia

PR Newswire March 17, 2020

Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection

PR Newswire March 12, 2020

Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp + Calm CBD Oral Applicator in Europe

PR Newswire March 10, 2020